In a study conducted by Cybulski et al. in 2011, the authors identified the c.470T>C PV in 7.1% of patients with BC (535 patients) as being the most common pathogenic CHEK2 variant in Polish people (Figure 3) [20]. This evidence concerns the gene CHEK2 and breast cancer.